Eye and ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, 200031, China
Location status: Recruiting
NCT Number: NCT06616506
This study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.
Interested in participating?
Request InfoAll sexes
Observational
Shanghai, Shanghai Municipality, 200031, China
Location status: Recruiting
High myopia cataract (HMC) is a complex cataract with high risk of blindness. At present, there are nearly 300 million people with high myopia in the world, which will increase to 500 million by 2020. Asia is the high incidence of myopia in the world. At present, there are more than 500 million people with myopia in China alone, of which nearly 100 million are high myopia, and this number is still growing rapidly. Correspondingly, the incidence rate of cataract with high myopia has also increased rapidly, which accounts for over 40% of cataract surgery.
In the early stage of the project team's analysis of refractive error after high myopia cataract surgery, it was found that the accuracy of intraocular lens calculation formula, which is widely recommended for high myopia cataract at present, is still worrying, because most of these formulas are based on the European and American eye data, while the European and American databases have few ultra high myopia data, which greatly affects the formula's accuracy In addition, the calculation of the existing formula needs to include multiple biometric indicators, and can be obtained based on complex algorithms. Artificial intelligence technology is exactly an effective means to solve this kind of problem. Therefore, based on the data of Asian population with high myopia and high incidence, the establishment of an intelligent model for the accurate calculation of high myopia cataract IOL will greatly improve the measurement accuracy Sex.
Therefore, the purpose of this study is to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Axial length ≥ 26 mm and patients with high myopia complicated by cataracts who visit our hospital.
Preoperative anterior segment photography and cataract severity assessment, along with fundus OCT examination, have been performed.
If surgical treatment is conducted, the postoperative follow-up period should be no less than 1 month.
There are no missing clinical data before and after the surgery.
Exclusion criteria
Patients who are unable to cooperate with the required examinations for this study.
Apply newly-invented AI models to assist in determining surgical plans and outcome prediction.
Time frame: 10 YEARS
Time frame: 8 years
Time frame: 10 years
Time frame: 10 years
Contact information is provided by the study sponsor or research team.
Shanghai High Myopia Study Group
Other
Acronym: AI-HMC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06743594
Cataract, Eye Diseases
Taipei, Taiwan
View Trial DetailsNCT07135570
AMD - Age-Related Macular Degeneration, Cardiovascular Diseases
Char Fasson, Bhola, Bangladesh
View Trial DetailsNCT03152747
Cataract, Eye Diseases
Vienna, State of Vienna, Austria
View Trial DetailsNCT05254587
Cataract, Eye Diseases
Bakersfield, California, United States
View Trial Details